Development of a Tumoroid Screening Platform to Empower Oncology Drug Development
- Spotlighting strategies to build a robust tumoroid platform capable of growing large volume 3D cultures in 24 well formats, enabling scalable expansion and consistent generation of physiologically relevant tumor microtissues
- Deploying high throughput compound screening across diverse tumoroid panels, capturing heterogeneity in growth, drug response and pathway dependency to rapidly identify promising agents
- Demonstrate the translational value of tumoroid models, showing how their architecture, cellular diversity and treatment responses more closely reflect patient tumors – and how these insights improve early decision making in oncology pipelines